Every successful clinical trial begins long before the first patient is enrolled. Before recruitment can start, research teams must complete regulatory submissions, activate study sites, organise essential documentation, define operational workflows and coordinate multiple stakeholders.
This phase, known as clinical trial start-up, is one of the most important stages of any study. Yet it also remains one of the biggest operational bottlenecks in clinical research. Delays during clinical trial start-up often affect the entire study timeline, increasing costs and postponing patient recruitment before the trial has even begun.
Why clinical trial start-up takes longer than expected
There is rarely a single reason why clinical trial start-up is delayed. More often, several operational processes happen simultaneously, each depending on different teams, approvals and documents.
A typical start-up phase may include:
- Regulatory submissions and approvals
- Ethics committee documentation
- Site activation activities
- Contract and budget management
- Study documentation review
- Team coordination across different organisations
When these activities are managed independently, keeping track of progress becomes increasingly difficult. Small delays accumulate, communication becomes more complex and project timelines quickly begin to slip.
For many organisations, the challenge is not the amount of work itself, but the difficulty of coordinating it efficiently.
Visibility is essential before the first patient
Many discussions about clinical research focus on recruitment, data collection or monitoring. However, these activities cannot begin until clinical trial start-up has been successfully completed.
This is why operational visibility during start-up is so important.
Research teams need to know which approvals are still pending, whether essential documents have been completed, which sites are ready for activation and whether study milestones are progressing according to plan. Having this information readily available allows project managers to identify bottlenecks early and intervene before delays affect the rest of the study.
Without this visibility, organisations often spend valuable time searching for updates instead of moving the project forward.
Connected processes reduce operational delays
Technology alone cannot eliminate every challenge associated with clinical trial start-up. However, connected digital processes can significantly reduce unnecessary administrative work and improve coordination between stakeholders.
Rather than managing regulatory documentation, operational milestones and study activities in separate environments, many organisations are moving towards integrated platforms that support the entire research lifecycle.
This approach helps teams maintain consistency, improve collaboration and reduce the risk of duplicated work throughout the start-up phase.
How Xolomon supports clinical trial start-up
At Xolomon, we believe that efficient clinical trial start-up begins with connected clinical operations rather than isolated software tools.
Our CTMS has been designed to support the complete lifecycle of a clinical study, including regulatory processes, patient recruitment, financial management, scheduling, documentation and operational reporting. It also provides real-time KPIs, customised dashboards and visibility into approvals, signatures, study costs and overall research status, helping research teams monitor progress from a single environment.
In addition, Xolomon’s modular ecosystem integrates solutions such as eCRD, eTMF and ePRO, allowing organisations to connect different stages of clinical research while adapting the platform to the specific requirements of each study. Introducing these digital tools early in the study timeline helps avoid fragmented workflows, improves coordination during site start-up and reduces the operational burden throughout the trial.
A strong start leads to a stronger study
It is easy to think of clinical trial start-up as simply the preparation phase before «real» research begins. In reality, it lays the foundation for everything that follows.
When start-up activities are well organised, connected and visible, research teams are better positioned to activate sites on time, begin recruitment sooner and maintain control throughout the study lifecycle.
As clinical trials become more complex, improving clinical trial start-up is no longer just about saving time. It is about creating the operational foundations that allow every subsequent phase of the study to run more efficiently.
